Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
After finishing at $44.47 in the prior trading day, Guardant Health Inc (NASDAQ: GH) closed at $44.40, down -0.16%. In other words, the price has decreased by -$0.16 from its previous closing price. On the day, 2.73 million shares were traded. GH stock price reached its highest trading level at $44.61 during the session, while it also had its lowest trading level at $41.79.
Ratios:
Our goal is to gain a better understanding of GH by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.85 and its Current Ratio is at 6.22.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Barclays on January 23, 2025, initiated with a Overweight rating and assigned the stock a target price of $60.
On June 28, 2024, Guggenheim Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $36.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 17 ’25 when Tariq Musa sold 116 shares for $37.58 per share. The transaction valued at 4,359 led to the insider holds 2,944 shares of the business.
Tariq Musa bought 116 shares of GH for $4,359 on Jan 17 ’25. On Dec 18 ’24, another insider, Tariq Musa, who serves as the Director of the company, sold 116 shares for $34.85 each. As a result, the insider received 4,043 and left with 2,810 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GH now has a Market Capitalization of 5485842432 and an Enterprise Value of 5794890752. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.92. Its current Enterprise Value per Revenue stands at 8.371 whereas that against EBITDA is -15.001.
Stock Price History:
The Beta on a monthly basis for GH is 1.50, which has changed by 1.0829041 over the last 52 weeks, in comparison to a change of 0.21659255 over the same period for the S&P500. Over the past 52 weeks, GH has reached a high of $50.89, while it has fallen to a 52-week low of $15.81. The 50-Day Moving Average of the stock is 15.63%, while the 200-Day Moving Average is calculated to be 51.32%.
Shares Statistics:
The stock has traded on average 2.07M shares per day over the past 3-months and 2288550 shares per day over the last 10 days, according to various share statistics. A total of 123.16M shares are outstanding, with a floating share count of 117.64M. Insiders hold about 4.79% of the company’s shares, while institutions hold 104.06% stake in the company. Shares short for GH as of 1736899200 were 7364075 with a Short Ratio of 3.56, compared to 1734048000 on 8254570. Therefore, it implies a Short% of Shares Outstanding of 7364075 and a Short% of Float of 6.21.
